title: Short-term and subchronic repeated exposure studies with 5-ethylidene-2-norbornene vapor in the rat.
abstract: 5-Ethylidene-2-norbornene (ENB) is an industrial chemical whose physical properties indicate a likelihood for vapor exposure to humans. The potential for target organ or cumulative toxicity was investigated in rats exposed for 6 h per day for 9 days over an 11-day period, or 66 or 67 days over 14 weeks; 4- week recovery animals were added to the 14-week study. Mean analytically measured ENB vapor concentrations (+/-SD) were 52 +/- 1.5, 148 +/- 2.3 and 359 +/- 4.2 ppm for the 9-day study and 4.9 +/- 0.14, 24.8 +/- 1.23 and 149 +/- 4.40 ppm for the subchronic study. There were no mortalities, and clinical signs were limited to periocular swelling and/or encrustation, and urogenital area wetness. Body weight gain was decreased in the 9-day 359 ppm females and in the subchronic 24.8 and 149 ppm males. A minimal macrocytic anemia was present in subchronically exposed males, which resolved during the recovery period. In the 9-day study increased liver weight was associated with minimal centrilobular hepatocytomegaly and cytoplasmic basophilia with no degenerative or serum biochemical liver function changes, suggesting an adaptive response. Only relative liver weights were increased in the subchronic 149 ppm males, and no histopathological findings were observed. Principal target organ effects were to the thyroid gland, which showed an exposure concentration-related, but not exposure time-related, depletion of follicular colloid that resolved during the recovery period, together with light microscopic evidence for a hypertrophic and hyperplastic response in the follicular epithelium that resolved more slowly. The thyroid colloid depletion was a graded effect without a clear no-effect concentration, but was not accompanied by any clinical or clear biochemical evidence for thyroid dysfunction. A no-effect concentration of 4.9 ppm was established for the follicular cytological effects.
authors.affiliation: Applied Toxicology Group, Union Carbide Corporation, Danbury, Connecticut 06817-0001, USA.
authors.forename: B
authors.initials: B
authors.lastname: Ballantyne
authors.forename: J C
authors.initials: JC
authors.lastname: Norris
authors.forename: D E
authors.initials: DE
authors.lastname: Dodd
authors.forename: D R
authors.initials: DR
authors.lastname: Klonne
authors.forename: P E
authors.initials: PE
authors.lastname: Losco
authors.forename: D A
authors.initials: DA
authors.lastname: Neptun
authors.forename: S C
authors.initials: SC
authors.lastname: Price
authors.forename: P
authors.initials: P
authors.lastname: Grasso
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D001772:Blood Cell Count / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002273:Carcinogens / Q000008:administration & dosage / Q000633:toxicity*; D003404:Creatinine / Q000652:urine; D004326:Drinking / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D005260:Female; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008297:Male; D009636:Norbornanes / Q000633:toxicity*; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011916:Rats, Inbred F344; D013961:Thyroid Gland / Q000187:drug effects* / Q000473:pathology; D013963:Thyroid Hormones / Q000097:blood
chemical_list: D002273:Carcinogens; D009636:Norbornanes; D013963:Thyroid Hormones; C108262:5-ethylidene-2-norbornene; D003404:Creatinine